Higher Scientific Officer - Targeted radionuclide therapy

Apply

Location:

Sutton

Department:

Preclinical Molecular Imaging

Salary Details:

Salary Range: £37,050 - £39,000 per annum

Contract:

Fixed term

Contract Length:

Not Specified

Advertising End Date:

17 Nov 2024

Home
Vacancies
Higher Scientific Officer - Targeted radionuclide therapy

Key Information

Salary: Commencement on the salary range is subject to comparable skills and experience. Future progression is based on annual performance review.

This role is eligible for ICR Sponsorship. Support will be provided for costs associated with Visa application. If you are considering relocating to the UK, further information can be found here.

Duration of Contract: Fixed Term for 12 months.

Hours per week: 35 hours per week (Full Time)

Closing Date: 17/11/2024

Job Details

Under the leadership of Gabriela Kramer-Marek, we are seeking to appoint a Higher Scientific Officer to join her group in order to manage studies relating to targeted radionuclide therapy (TRT) in both in vitro and in vivo models of glioblastoma.

Key Requirements

The successful candidate must have, M.Sc. of PhD in a relevant biological science, Knowledge of glioblastoma biology, Experience in molecular and cell biology techniques(e.g. DNA/RNA purification, confocal microscopy, FACS analysis, Western blotting, IHC), Good verbal and written communication skills, including good presentation skills.

Department/Directorate Information

The Division of Radiotherapy and Imaging is investigating new imaging methods to diagnose cancer, and ways in which advances in technology and molecular biology can improve radiation treatment. It is also increasingly concerned with the use of imaging to evaluate the response to treatment in vivo, through techniques measuring aspects of tumour biology.

Preclinical Molecular Imaging Group focuses on development of innovative preclinical imaging biomarkers for non-invasive and real-time mapping of specific proteins involved either in early tumour cell response or de novo resistance to new treatment combinations, with an emphasis on targeted cancer therapies and immunotherapies.

We encourage all applicants to access the job pack attached for more detailed information regarding this role.

About The Institute of Cancer Research

Why work for us?

As a member of staff, you'll have exclusive access to a range of staff benefits.

The ICR is committed to supporting overseas applicants applying for roles, please click here to find out further information.

The Institute of Cancer Research, London, is one of the world's most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. Further information about working at the ICR can be found here.

We look forward to receiving applications from all candidates, wherever in the world they are currently based. We will select those who display the potential to become, or to support, the world leading cancer researchers of the future based on their application and performance at interview. However, we particularly welcome British applicants from black and ethnic minority backgrounds, as they are under-represented within the ICR and nationwide in STEM roles.

Apply

Other jobs like this

Similar